Eris enters JV with MJ Pharma to commercialise insulins in domestic market

The business of the joint venture will be kickstarted with the launch of human insulin in the fourth quarter of FY22.

Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.